Transcenta Sets 28 August 2026 Board Meeting to Approve H1 2026 Results and Consider Interim Dividend

Bulletin Express

Aug 12

Transcenta Holding Limited has scheduled a board meeting for Friday, 28 August 2026. Directors will review and approve the Group’s interim financial results for the six months ended 30 June 2026 and deliberate on a potential interim dividend. Additional routine business matters may also be addressed during the session.

The announcement, dated 12 August 2026 and released in Hong Kong, confirms the participation of the full board: Executive Director, Chairman and Chief Executive Officer Dr. Xueming Qian; Non-executive Directors Dr. Li Xu and Dr. Han Sen Xu; and Independent Non-executive Directors Mr. Jiasong Tang and Ms. Helen Wei Chen.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/news/1167679547"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1167679547\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1167679547?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-08-12 17:08","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1167679547","market":"us","top_or_hot":-1,"title":"Transcenta Sets 28 August 2026 Board Meeting to Approve H1 2026 Results and Consider Interim Dividend","media":"Bulletin Express","content":"<p>Transcenta Holding Limited has scheduled a board meeting for Friday, 28 August 2026. Directors will review and approve the Group’s interim financial results for the six months ended 30 June 2026 and deliberate on a potential interim dividend. Additional routine business matters may also be addressed during the session.</p>\n<p>The announcement, dated 12 August 2026 and released in Hong Kong, confirms the participation of the full board: Executive Director, Chairman and Chief Executive Officer Dr. Xueming Qian; Non-executive Directors Dr. Li Xu and Dr. Han Sen Xu; and Independent Non-executive Directors Mr. Jiasong Tang and Ms. Helen Wei Chen.</p>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Transcenta Sets 28 August 2026 Board Meeting to Approve H1 2026 Results and Consider Interim Dividend</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nTranscenta Sets 28 August 2026 Board Meeting to Approve H1 2026 Results and Consider Interim Dividend\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1053168898\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Bulletin Express </p>\n<p class=\"h-time\">2026-08-12 17:08</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Transcenta Holding Limited has scheduled a board meeting for Friday, 28 August 2026. Directors will review and approve the Group’s interim financial results for the six months ended 30 June 2026 and deliberate on a potential interim dividend. Additional routine business matters may also be addressed during the session.</p>\n<p>The announcement, dated 12 August 2026 and released in Hong Kong, confirms the participation of the full board: Executive Director, Chairman and Chief Executive Officer Dr. Xueming Qian; Non-executive Directors Dr. Li Xu and Dr. Han Sen Xu; and Independent Non-executive Directors Mr. Jiasong Tang and Ms. Helen Wei Chen.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"06628","symbol_name":"创胜集团医药-B","start_time":0,"source_url":"","article_id":"1167679547","we_media_id":"1053168898","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1167679547","pubTimestamp":1786525737,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Bulletin Express","introduction":"Full Coverage of HK & US Stock Announcements","home_visible":1,"id":"1053168898","head_image":"https://community-static.tradeup.com/news/ed558ed0402cbe7d1ef4d150458f2b2e"},"summary":"Transcenta Holding Limited has scheduled a board meeting for Friday, 28 August 2026. Directors will review and approve the Group’s interim financial results for the six months ended 30 June 2026 and...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"06628":"创胜集团医药-B"},"translate_title":"Transcenta 定于 2026 年 8 月 28 日召开董事会会议，批准 2026 年上半年业绩并考虑中期股息","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"06628":1},"content_text":"Transcenta Holding Limited has scheduled a board meeting for Friday, 28 August 2026. Directors will review and approve the Group’s interim financial results for the six months ended 30 June 2026 and deliberate on a potential interim dividend. Additional routine business matters may also be addressed during the session.\nThe announcement, dated 12 August 2026 and released in Hong Kong, confirms the participation of the full board: Executive Director, Chairman and Chief Executive Officer Dr. Xueming Qian; Non-executive Directors Dr. Li Xu and Dr. Han Sen Xu; and Independent Non-executive Directors Mr. Jiasong Tang and Ms. Helen Wei Chen.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"0","news_tag":"conferences,SGX","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":1,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"}}}